The economic burden of COPD.

COPD is one of the leading causes of morbidity and mortality worldwide and imparts a substantial economic burden on individuals and society. Despite the intense interest in COPD among clinicians and researchers, there is a paucity of data on health-care utilization, costs, and social burden in this population. The total economic costs of COPD morbidity and mortality in the United States were estimated at $23.9 billion in 1993. Direct treatments for COPD-related illness accounted for $14.7 billion, and the remaining $9.2 billion were indirect morbidity and premature mortality estimated as lost future earnings. Similar data from another US study suggest that 10% of persons with COPD account for > 70% of all medical care costs. International studies of trends in COPD-related hospitalization indicate that although the average length of stay has decreased since 1972, admissions per 1,000 persons per year for COPD have increased in all age groups > 45 years of age. These trends reflect population aging, smoking patterns, institutional factors, and treatment practices.

[1]  G. Guyatt,et al.  Economic analysis of respiratory rehabilitation. , 1997, Chest.

[2]  W. Dement,et al.  Introduction , 1998, Thorax.

[3]  T. Petty,et al.  Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, D.C., October 15-16, 1993. , 1994, American journal of respiratory and critical care medicine.

[4]  D. Wood,et al.  Economic aspects of lung volume reduction surgery. , 1996, Chest.

[5]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[6]  S. Ramsey,et al.  Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996. , 1998, Chest.

[7]  D. Sclar,et al.  Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expenditures. , 1994, Clinical therapeutics.

[8]  M. Raw,et al.  Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. , 1998, Thorax.

[9]  F. Sonnenberg,et al.  Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study. , 1993, Chest.

[10]  J. Wilson,et al.  Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. , 1999, Chest.

[11]  B. Fleury,et al.  The cost of treating COPD patients with long-term oxygen therapy in a French population. , 1996, Chest.

[12]  G. Diette,et al.  Capitation, managed care, and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[13]  J. Szidon,et al.  Lung volume reduction surgery: an analysis of hospital costs. , 1998, Chest.

[14]  A. Ries.  Position Paper of the American Association of Cardiovascular and Pulmonary Rehabilitation Scientific Basis of Pulmonary Rehabilitation , 1990 .

[15]  Tammy O. Tengs,et al.  Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  M. Koopmanschap,et al.  Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. , 1998, Chest.

[17]  H. Kerstjens,et al.  Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. , 1995, American journal of respiratory and critical care medicine.

[18]  G. Raghu,et al.  The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. , 1995, Chest.

[19]  Se-Ge Ma,et al.  Cost-utility of lung transplantation: a pilot study. , 1997 .

[20]  H. Folgering,et al.  Education and cost/benefit ratios in pulmonary patients. , 1994, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.